Ario Pharma acquires PharmEste’s TRPA1 research assets
Cambridge, UK-based biopharma company Ario Pharma says it has acquired the TRPA1 antagonist research program previously owned by privately-held Italian firm PharmEste. The acquired...
SBL Vaccin Cholera Vaccine Production, Sweden
In the second quarter of 2003 the Swedish vaccine producer, SBL Vaccin AB, brought on-line a major extension and upgrade to the vaccine...
Polpharma Dry Forms II Production Facility, Poland
Polpharma began production at its new Dry Forms II plant (Oddzial Formy Suche II – FSII Solid Forms Branch) in Starogard Gdansk, Poland in...
GlaxoSmithKline Vaccine Manufacturing Plant, St-Amand-Les-Eaux, France
GSK Biologicals, the vaccine division of the pharmaceutical and healthcare company GlaxoSmithKline (GSK), announced its decision to build a new production facility in St-Amand-Les-Eaux,...
Cordis Corporation Manufacturing Plant, Cashel, Co Tipperary, Ireland
Cordis Corporation was established in Miami in Florida, US in 1959. The company is a subsidiary of the pharmaceutical major Johnson & Johnson, producing...
Bidachem Active Pharmaceutical Ingredients Plant, Bergamo, Italy
Bidachem SPA is one of the major manufacturers of fine chemicals and active pharmaceutical ingredients (APIs) in Italy. The company became an affiliate of...
Signifor (Pasireotide) – Treatment for Cushing’s Disease, Germany
Signifor (SOM230 / Pasireotide) is a somatostatin analogue indicated for the treatment of patients with Cushing's disease for whom surgery has failed. The drug...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...